This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization US

Early Registration Savings Deadline Expires In

  • 00
  • 00
  • 00
  • 00
Delivered as a Hybrid Event
September 27-30, 2022Boston Convention and Exhibition Center

William Schaut
Senior Manager Global Cell Collection at Janssen Pharmaceuticals, Inc


Bill Schaut serves as the Senior Manager Global Cell Collection and Cryopreservation at Janssen. In his role, Bill is responsible for interpreting and implementing the regulatory requirements for cell and gene therapy starting material. Bill has over 30 years of experience in cell therapy products, vaccines, and large molecules. Bill received both his B.S. in Microbiology and Medical Technology certification from the Pennsylvania State University and his M.B.A. from La Salle University

Agenda Sessions

  • Regulatory Requirements for CAR T Starting Materials